Overexpression of EGF receptor is associated with spontaneous metastases of a human melanoma cell line in nude mice

Anticancer Research

Volumn 16, Issue 6 B, 1996, Pages 3557-3564

  Huang, Tien Shew W ^a   Rauth, Sikha ^a   Das Gupta, Tapas K ^a,b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b Department of Surgical Oncology ^*  (United States)

Author keywords

Epidermal growth factor receptor; Melanoma; Metastasis

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; PROTEIN P53;

ARTICLE; CANCER CELL CULTURE; CANCER TRANSPLANTATION; CONTROLLED STUDY; GENE MUTATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; MELANOMA CELL; METASTASIS; NORTHERN BLOTTING; NUDE MOUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; BLOTTING, NORTHERN; BLOTTING, SOUTHERN; DNA, NEOPLASM; HUMANS; MELANOCYTES; MELANOMA; MICE; MICE, NUDE; NEOPLASM PROTEINS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RNA, NEOPLASM; TUMOR CELLS, CULTURED;

EID: 0030499589     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Clark WH, Elder DE, Guerry D, Epstein MN, Greene MH, and Van Horn M: A study of tumor progression: the precursor lesions of superficial spreading and nodular melanomas. Human Pathology 15: 1147-1165, 1984.
2. Elder DE, Rodeck U, Thurin J, Cardillo F, Clark WH, Rosemary S, and Herlyn M: Antigenic profile of tumor progression stages in human melanocytic nevi and melanomas. Cancer Res 49: 5091-5096, 1989.
3. Holzmann B, Broecker EB, Lehmann JM, Ruiter DJ, Sorg C, Riethmueller C, and Johnson JP: Tumor progression in human malignant melanoma: Five stages defined by their antigenic phenotypes. Int J Cancer 39: 466-471, 1987.
4. Gullick W: Prevalence of aberrant expression of the epidermal growth factor receptor in human cancers. J British Medical Bulletin 47: 87-98, 1991.
5. De Wit PEJ, Moretti S, Koenders PG, Weterman MAJ, Van Muijen GNP, Gianotti B, and Ruiter DJ: Increasing epidermal growth factor receptor expression in human melanocytic tumor progression. J Invest Dermatol 99: 168-173, 1992.
6. Singletary SE, Baker FL, Spitzer G, Tucker SL, Tomasovic B, Brock WA, Ajani JA, and Kelly AM: Biological effect of epidermal growth factor on the in vitro growth of human tumors. Cancer Res 47: 403-406, 1987.
7. Rodeck U and Herlyn M: Growth factors in melanoma. Cancer and Metastasis Reviews 10: 89-101, 1991.
8. Real FX, Rettig WJ, Chesa PG, Melamed MR, Old LJ, and Mendelsohn J: Expression of epidermal growth factor receptor in human cultured cells and tissues: Relationship to cell lineage and stage of differentiation. Cancer Res 46: 4726-4734, 1986.
9. Vuk-Pavlovic S, Opara EC, Levanat S, Vrbanec D, and Pavelic K: Autocrine tumor growth regulation and tumor-associated hypoglycemia in murine melanoma B 16 in vivo. Cancer Res 46: 2208-2213, 1986.
10. Mueller B, Romerdahl CA, Trent JM, and Reisfeld, RA: Suppression of spontaneous melanoma metastasis in scid mice with an antibody to the epidermal growth factor receptor. Cancer Res 51: 2193-2198, 1991.
11. Van Muijen GN, Cornelissen LM, Jansen CF, Figdor CG, Johnson JP, Brocker FB, and Ruiter DJ: Antigen expression of metastasizing and non-metastasizing human melanoma cells xenografted into nude mice. Clin Exp Metastasis 9: 259-272, 1991.
12. Rauth S, Kichina J, Green A, Bratescu L, and Das Gupta TK: Establishment of a human melanoma cell line lacking p53 expression and spontaneously metastasizing in nude mice. Anticancer Res 14: 2457-2464, 1994.
13. Akiyama S, Fojo A, Hanover JA, Pastan I, and Gottesman MM: Isolation and genetic characterization of human KB cell lines resistant to multiple drugs. Somat Cell Molec Genet 11: 117-126, 1985.
14. Eisinger M and Marko O: Selective proliferation of normal human melanocytes in vitro in the presence of phorbol ester and cholera toxin. Proc Natl Acad Sci USA 79: 2018-2022, 1982.
15. Guesdon J, Ternynck T, and Avrameas S: The use of avidin-biotin interaction in immunoenzymatic techniques. J Histochem Cytochem 27: 1131-1139, 1979.
16. Kohler G and Mistein C: Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256: 495-497, 1975.
17. Chirgwin J, Przybyla A, MacDonald R, and Rutter WJ: Isolation of biologically active ribonucleic acid from sources enriched in ribo-nuclease. Biochem 18: 5294-5299, 1979.
18. Sambrook J, Fritsch EF, and Maniatis T: Molecular Cloning: A Laboratory Manual. 2nd Ed. Cold Spring Harbor, New York. Cold Spring Harbor Laboratory Press, 1989.
19. Xu Y, Ishii S, Clark AJL, Sullivan M, Wilson RK, Ma DP, Roe BA, Merlino GT, and Pastan I: Human epidermal growth factor receptor cDNA is homologous to a variety of RNAs overproduced in A431 carcinoma cells. Nature 309: 806-810, 1984.
20. Fort P, Marty L, Piechaczylk M, Sabrouty SE, Dani C, Jeanteur P, and Blanchard JM: Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate-dehydrogenase multigene family. Nucleic Acids Res 13: 1431-1442, 1985.
21. Rauth S, Hoganson GE, and Davidson RL: Bromodeoxyuridine- and cyclic AMP-mediated regulation of tyrosinase in Syrian hamster melanoma cells. Somat Cell Mol Genet 16: 583-592, 1990.
22. Feinberg AP and Vogelstein B: A technique for radiolabelling DNA restriction endonuclease fragments to high activity. Anal Biochem 132: 6-13, 1983.
23. Rauth S, Yang KG, Seibold AM, Ingolia DE, Ross SR, Yeung C, Rich GC: Murine adenosine deaminase gene promoter supports diverse tissue-specific gene expression. Somat Cell and Mol Genet 16: 129-141, 1990.
24. Davidson NE, Gelmann EP, Lippman ME, and Dickson RB: Epidermal growth factor receptor gene expression in estrogen receptor-positive and negative human breast cancer cell lines. Molecular Endocrinology 1: 216-223, 1987.
25. Pimental E: Epidermal growth factor. In: Hormones. Growth factors, and Oncogenes. Boca Raton, Florida. CRC Press, 1987: pp 111-140.
26. Wells A: The epidermal growth factor receptor and its ligands. In: Oncogenes (Benz C and Liu E, eds). Boston. Kluwer Academic Publishers, 1989: pp 143-168.
27. Rosner MR: Review: Regulation of the epidermal growth factor receptor by growth-modulating agents. Biotechnology and Applied Biochemistry 12: 473-477, 1990.
28. Koprowski H, Herlyn M, Balaban G, Parmiter A, Ross A, and Nowell P: Expression of the receptor for epidermal growth factor correlates with increased dosage of chromosome 7 in malignant melanoma. Somat Cell and Mol Genet 11: 297-302, 1985.
29. Chenevix-Trent G, Martin NG, and Ellem KA: Gene expression in melanoma cell lines and cultured melanocytes: Correlation between levels of c-src-1, c-myc and p53. Cancer Res 50: 1190-1193, 1990.
30. Ullrich A, Coussens L, Hayflick JS, Dull TJ, Gray A, Tam AW, Lee J, Yarden Y, Libermann TA, Schlessinger J, Downward J, Mayes ELV, Whittle N, Waterfield MD, and Seeburg PH: Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells. Nature 309: 418-425, 1984.
31. Ishitoya J, Toriyama M, Oguchi N, Kitamura K, Ohshima M, Asano K, and Yamamoto T: Gene amplification and overexpression of EGF receptor in squamous cell carcinomas of the head and neck. Br J Cancer 59: 559-562, 1989.
32. Linnenbach AJ, Huebner K, Reddy EP, Herlyn M, Parmiter AH, Nowell PC, and Koprowski H: Structural alteration in the myc protooncogene and deletion within the gene encoding a-type protein kinase C in human melanoma cell lines. Proc Natl Acad Sci USA 85: 74-78, 1988.
33. Yongshan Y, DeBauche DM, and Stanley WS: Epidermal growth factor receptor expression in a retinoic acid-treated human melanoma cell line. Cancer Genet Cytogenet 46: 261-269, 1990.
34. Rauth S, Green A, Bratescu L, and Das Gupta TK: Letter to editor: chromosome abnormalities in metastatic melanoma. In vitro Cell Dev Biol 30A: 79-84, 1994.
35. Houghton AN, Real, FX, Davis LJ, Cordon-Cardo C, and Old LJ: Phenotypic heterogeneity of melanoma: Relation to the differentiation program of melanoma cells. J Exp Med 164: 812-829, 1987.